Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components (Tables)

v3.24.1.1.u2
Balance Sheet Components (Tables)
 3 Months Ended
Mar. 31, 2024
Balance Sheet Components [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets as of December 31, 2023 and March 31, 2024 consisted of the following (in thousands):
    As of     As of  
    December 31,     March 31,  
    2023     2024  
             
Prepaid directors and officers’ liability insurance premiums   $ 270       146  
Prepaid preclinical services     3,103       2,097  
Other     325       503  
Total   $ 3,698       2,746  

 
Schedule of Property, Plant and Equipment Property, plant and equipment as of December 31, 2023 and March 31, 2024 consisted of the following (in thousands):
    As of     As of  
    December 31,     March 31,  
    2023     2024  
             
Leasehold improvements   $ 21       21  
Furniture and fixtures     21       21  
Subtotal     42       42  
Less accumulated depreciation     (16 )     (19 )
Net   $ 26       23  
Schedule of Accounts Payable Accounts payable as of December 31, 2023 and March 31, 2024 consisted of the following (in thousands):
    As of     As of  
    December 31,     March 31,  
    2023     2024  
             
Trade accounts payable   $ 821       1,171  
Credit card liability     18       69  
Total   $ 839       1,240  
Schedule of Accrued Liabilities Accrued liabilities as of December 31, 2023 and March 31, 2024 consisted of the following (in thousands):
    As of     As of  
    December 31,     March 31,  
    2023     2024  
             
Accrued labor costs   $ 1,917     $ 1,965  
Accrued drug development costs     1,034       1,336  
Other     283       250  
Total   $ 3,234     $ 3,550